BEST UNLIMITED TURBO LONG CERTIFICATE - NOVARTIS N Share Price

Certificat

93BVZ

DE000CN6GLB9

Real-time Euronext Paris 08:17:55 30/04/2024 BST
7.649 EUR +2.12% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - NOVARTIS N
Current month+2.04%
1 month+2.04%
Date Price Change Volume
30/04/24 7.649 +2.12% 6
29/04/24 7.49 -2.38% 109
26/04/24 7.673 -2.13% 107
25/04/24 7.84 +2.27% 109
24/04/24 7.666 +0.76% 101

Real-time Euronext Paris

Last update April 30, 2024 at 08:17 am

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer Société Générale Société Générale
93BVZ
ISINDE000CN6GLB9
Date issued 10/12/2015
Strike 51.71 CHF
Maturity Unlimited
Parity 5 : 1
Emission price 4.11
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 8.814
Lowest since issue 0.71

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
97.56 USD
Average target price
108.5 USD
Spread / Average Target
+11.20%
Consensus
  1. Stock Market
  2. Certificates
  3. 93BVZ Certificat